Company Hanmi Pharm. Co., Ltd.

Equities

A128940

KR7128940004

Pharmaceuticals

End-of-day quote Korea S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
342,000 KRW -0.87% Intraday chart for Hanmi Pharm. Co., Ltd. +2.40% -2.98%

Business Summary

Hanmi Pharm Co Ltd is a Korea-based company principally engaged in the manufacturing and sale of pharmaceuticals. The Company operates its business through three segments. The Pharmaceuticals segment manufactures and sells tablets, capsules, injections, syrups, powders and raw materials used in the treatment of hypertension, reflux esophagitis, influenza type A and influenza type B virus infections and hyperlipidemia, among others. The Other segment is engaged in the materials processing. The Export segment produces and sells products such as powders and injections, and exports technologies.

Number of employees: 2,238

Sales per Business

KRW in Million2022Weight2023Weight Delta
Medicine
73.0 %
975,021 73.2 % 1,087,780 73.0 % +11.56%
Overseas Medicine
26.7 %
350,640 26.3 % 397,513 26.7 % +13.37%
Drug Substance
0.4 %
5,885 0.4 % 5,594 0.4 % -4.95%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
59.7 %
826,082 62.0 % 890,760 59.7 % +7.83%
China
27.2 %
356,108 26.7 % 404,849 27.2 % +13.69%
Other
5.1 %
63,687 4.8 % 75,478 5.1 % +18.51%
United States
4.6 %
40,869 3.1 % 67,990 4.6 % +66.36%
Japan
3.5 %
44,800 3.4 % 51,811 3.5 % +15.65%

Managers

Managers TitleAgeSince
Chief Executive Officer 51 -
Compliance Officer 52 -
Chief Tech/Sci/R&D Officer 62 -
Director/Board Member 64 -
Corporate Officer/Principal 54 -
Corporate Officer/Principal 62 -
Corporate Officer/Principal 49 -

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 51 -
Director/Board Member 64 -
Director/Board Member 68 17-03-09
Director/Board Member 70 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 12,808,582 6,392,046 ( 49.90 %) 120,463 ( 0.9405 %) 49.90 %

Shareholders

NameEquities%Valuation
5,306,122 41.42 % 1 331 M ₩
National Pension Service of Korea
11.12 %
1,424,437 11.12 % 357 M ₩
1,008,369 7.871 % 253 M ₩
125,329 0.9783 % 31 M ₩
Nordea Investment Funds SA
0.1386 %
17,750 0.1386 % 4 M ₩
Sjunde AP-fonden
0.1244 %
15,933 0.1244 % 4 M ₩
State Street Global Advisors Ltd.
0.1156 %
14,808 0.1156 % 4 M ₩
KB Asset Management Co., Ltd.
0.1005 %
12,876 0.1005 % 3 M ₩
Northern Trust Fund Managers (Ireland) Ltd.
0.0895 %
11,467 0.0895 % 3 M ₩
Nordea Investment Management AB
0.0623 %
7,979 0.0623 % 2 M ₩

Holdings

NameEquities%Valuation
125,329 0.98% 31,435,781 $
2,989,415 19.03% 5,380,947 $

Company contact information

Hanmi Pharmaceutical Co., Ltd.

214 Muha-ro Paltan-myeon

18536, Hwaseong-si

+82 3 1350 5600

http://www.hanmipharm.com
address Hanmi Pharm. Co., Ltd.(A128940)

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
342,000 KRW
Average target price
408,486 KRW
Spread / Average Target
+19.44%
Consensus

Quarterly revenue - Rate of surprise